Agilent Technologies, Inc. - SIC # 3850 -

Ticker Exchange SIC # Website Latest Ticker
A New York 3850 www.agilent.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Agilent Technologies, Inc.

3D Cell Culture - Global Strategic Business Report: Capitalize on 13.9% CAGR to US$3.9 Billion by 2030 as Agilent, Corning, GE Healthcare and Bio-Rad Reshape Drug Discovery - Nov 3rd, 2026 8:12 am
Metabolomics - Global Strategic Business Report: Capitalize on an 11.7% CAGR to Secure the $7.1 Billion 2030 Market as Thermo Fisher, Agilent, Bruker, Waters, and Metabolon Reshape Competition - Nov 3rd, 2026 8:09 am
Commercial Biotechnology Separation Systems - Global Strategic Business Report: Capture the $6.5B Surge by 2032 as 3M, Agilent, Merck KGaA, and Sartorius Disrupt Bioprocessing - Nov 3rd, 2026 8:07 am
Electrophoresis Equipment and Supplies - Global Strategic Business Report 2026: Secure Share of a $3.1 Billion Market by 2032, Led by Agilent, Bio-Rad, SCIEX, and Merck - Nov 3rd, 2026 7:47 am
What Are Danaher Investors Betting On? - Nov 3rd, 2026 4:56 am
Forensic Technologies and Services - Global Strategic Business Report: Secure Share of a $44.7B Market by 2030 as Thermo Fisher, Illumina, Agilent and BAE Systems Accelerate AI-Led Forensics - Nov 2nd, 2026 8:49 am
Agilent Launches 5987A MSD with GC Assist for Faster, Smarter GC/MS Workflows - Nov 2nd, 2026 6:00 am
What Sent Illumina Stock Lower? - Nov 1st, 2026 6:23 pm
Global Ribonucleic Acid (RNA) Interference Technology Market Report 2026-2030 | Capitalize on Precision Gene Silencing with Alnylam, Arrowhead, Silence Therapeutics, and Roche - Oct 30th, 2026 8:42 am
Global Fetal Aneuploidy Confirmation Testing Market Report 2026 | Capitalize on 10.6% CAGR to $2.36 Billion by 2030 with Thermo Fisher, Labcorp, Quest Diagnostics and Illumina - Oct 30th, 2026 8:27 am
Is Agilent Technologies (A) Fully Valued Following Its University Of Chicago Energy Storage Partnership? - Oct 29th, 2026 3:12 pm
Agilent to Announce Fourth-Quarter Fiscal Year 2026 Financial Results on Nov. 23 - Oct 29th, 2026 2:15 pm
How Investors Are Reacting To Agilent Stock As It Opens Energy Materials Research Center - Oct 29th, 2026 10:08 am
AI in Pathology Market Size, Share, Trends, and Global Forecast 2026-2036 | A $1.72 Billion Opportunity Featuring Profiles of Key Players Leica Biosystems (Danaher), Roche, Hamamatsu Photonics, Fujifilm, Agilent Technologies - Oct 29th, 2026 10:06 am
Long Oligo Pool Synthesis for Capture Global Market Report 2026 | Capitalize on $3.31B by 2030 as Twist Bioscience, Agilent, Eurofins and BGI Scale AI-Driven Precision Oncology - Oct 29th, 2026 9:29 am
Global Bead-Linked Transposase Library Kits Market Report 2026 | Capitalize on 11.6% CAGR Through 2030 as Illumina, Thermo Fisher, Roche, and Agilent Scale AI-Automated Sequencing - Oct 29th, 2026 9:25 am
ALGN Q3 Earnings & Revenues Beat, '26 Sales View Down, Stock Falls - Oct 29th, 2026 9:06 am
Molecular Spectroscopy - Global Strategic Business Report: Capitalize on the Surge to $8.7 Billion by 2032 as Agilent, Bruker, Danaher, and Thermo Fisher Scientific Accelerate AI-Driven Analysis - Oct 29th, 2026 8:55 am
Global Pooled CRISPR Screening Market Report 2026 | Capitalize on 16.1% CAGR as Thermo Fisher, Merck, Danaher and Agilent Accelerate AI-Driven Multi-Omics Workflows - Oct 29th, 2026 8:33 am
3 Reasons to avoid A and 1 stock to buy instead - Oct 28th, 2026 4:54 pm